Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201212074 Principal Investigator: Stockerl-Goldstein, Keith
Title: A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCl for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Phase: II Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:

The purpose of this trial is to confirm the safety and efficacy of high-dose Melphalan HCL for Injection as a myeloablative conditioning regimen in multiple myeloma patients undergoing autologous transplantation.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)